These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12555068)
1. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Kanai M; Konda Y; Nakajima T; Izumi Y; Kanda N; Nanakin A; Kubohara Y; Chiba T Oncogene; 2003 Jan; 22(4):548-54. PubMed ID: 12555068 [TBL] [Abstract][Full Text] [Related]
2. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Kanda N; Seno H; Konda Y; Marusawa H; Kanai M; Nakajima T; Kawashima T; Nanakin A; Sawabu T; Uenoyama Y; Sekikawa A; Kawada M; Suzuki K; Kayahara T; Fukui H; Sawada M; Chiba T Oncogene; 2004 Jun; 23(28):4921-9. PubMed ID: 15077160 [TBL] [Abstract][Full Text] [Related]
3. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Paner GP; Silberman S; Hartman G; Micetich KC; Aranha GV; Alkan S Anticancer Res; 2003; 23(3B):2253-60. PubMed ID: 12894500 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition of activator protein-1 on the growth of gastric cancer by octreotide]. Wang CH; Tang CW Ai Zheng; 2002 Aug; 21(8):850-4. PubMed ID: 12478891 [TBL] [Abstract][Full Text] [Related]
5. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling. Zhang T; Ma J; Cao X Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832 [TBL] [Abstract][Full Text] [Related]
7. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720 [TBL] [Abstract][Full Text] [Related]
8. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells. Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683 [TBL] [Abstract][Full Text] [Related]
9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
10. Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. Pai R; Lin C; Tran T; Tarnawski A Biochem Biophys Res Commun; 2005 Jun; 331(4):984-92. PubMed ID: 15882975 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Ni Z; Lou W; Leman ES; Gao AC Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680 [TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Mora LB; Buettner R; Seigne J; Diaz J; Ahmad N; Garcia R; Bowman T; Falcone R; Fairclough R; Cantor A; Muro-Cacho C; Livingston S; Karras J; Pow-Sang J; Jove R Cancer Res; 2002 Nov; 62(22):6659-66. PubMed ID: 12438264 [TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
14. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells. Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the roles of STAT1 and STAT3 signal transduction pathways in mammalian lens development. Ebong S; Chepelinsky AB; Robinson ML; Zhao H; Yu CR; Egwuagu CE Mol Vis; 2004 Feb; 10():122-31. PubMed ID: 14978477 [TBL] [Abstract][Full Text] [Related]
16. Roles of activated Src and Stat3 signaling in melanoma tumor cell growth. Niu G; Bowman T; Huang M; Shivers S; Reintgen D; Daud A; Chang A; Kraker A; Jove R; Yu H Oncogene; 2002 Oct; 21(46):7001-10. PubMed ID: 12370822 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961 [TBL] [Abstract][Full Text] [Related]
18. Biphasic regulation of extracellular-signal-regulated protein kinase by leptin in macrophages: role in regulating STAT3 Ser727 phosphorylation and DNA binding. O'Rourke L; Shepherd PR Biochem J; 2002 Jun; 364(Pt 3):875-9. PubMed ID: 12049654 [TBL] [Abstract][Full Text] [Related]
19. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187 [TBL] [Abstract][Full Text] [Related]
20. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells. Fung MM; Rohwer F; McGuire KL Cell Signal; 2003 Jun; 15(6):625-36. PubMed ID: 12681450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]